Drug Story

Dr. Aaron Carroll, a physician and health researcher, dives deep into the complex world of antidepressants, focusing on Zoloft. He reveals the challenges of pinpointing effective treatments amid the rising rates of depression. The conversation explores how SSRIs like Zoloft became mainstream, the oversimplification of the serotonin imbalance theory, and the reality of trial-and-error in finding the right medication. Carroll also discusses the importance of alternative treatments and the need for better research into effective options for patients.

Rita Redberg, a cardiologist and professor at UCSF, critiques the widespread use of statins, particularly atorvastatin, for cholesterol management. She highlights the controversy over who should be prescribed these medications and uncovers that many may not receive significant benefits. Rita discusses the disconnect between clinical trial reports and real-world side effects, as well as concerns around lifestyle changes among statin users. Ultimately, she champions diet and exercise as key preventive measures for heart disease, rather than reliance on medications.

Gideon Lack, professor of pediatric allergy at King’s College London and lead of the LEAP study, explains surprising links between public health advice and rising food allergies. He recounts the Israeli observation about early peanut exposure and describes how that led to the landmark LEAP trial. The conversation also covers epinephrine autoinjector history, commercialization, and new prevention and treatment directions.

Diabetes and anxiety and insomnia and depression and food allergies. For every modern malady, there are drugs promising to fix it. SO MANY DRUGS.But they never really fix the problem, do they? Yes, drugs can help people manage their disease. They treat the symptoms. But they rarely remedy what caused the disease in the first place. And therein lies a story. Launching Jan. 6, 2026. Get full access to Drug Story at www.drugstory.co/subscribe